Dear ILD Community,
I am pleased to share with you our recently published article:
π¨Genetics and environmental factors in interstitial lung diseases: current and future perspectives on early diagnosis of high-risk cohorts π¨
Great teamwork! Many thanks Stefan Stanel and Jack Callum ππ #ManchesterILDteam
#Genetics #ILD #FPF #telomere π«π§¬
https://www.frontiersin.org/articles/10.3389/fmed.2023.1232655/full
#manchesterildteam #genetics #ILD #fpf #telomere
π₯Our new #review #article is out!
βIs #PulmonaryHypertension the same or a different entity when associated with #COPD or #ILDβ
πFind out more about similarities & differences between PH-COPD & PH-ILD
πhttp://journals.lww.com/co-pulmonarymedicine/Abstract/9900/Pulmonary_hypertension_in_interstitial_lung.81.aspx
A little teaser trailer in the thread π§΅π
1/4
#review #article #PulmonaryHypertension #COPD #ILD
I would like to share our recently published article:
Present and future perspectives in early diagnosis and monitoring for progressive fibrosing interstitial lung diseases
#ILD #PFILD #PPF #earlydiagnosis #monitoring #perspectives π« π§¬
https://www.frontiersin.org/articles/10.3389/fmed.2023.1114722/full
#ILD #pfild #PPF #earlydiagnosis #monitoring #perspectives
RT @AshimaMakol@twitter.com
Much needed until we have practice guidelines!
β¨Expert consensus on #SSc-#ILD π«β¨
π Screening
π T/t criteria
π M/M Algorithm ππ
π Monitoring
π«consensus on use of CYC, RTX, AZA, GCs, or TCZ as initial therapy
π¦π: https://twitter.com/AshimaMakol/status/1615148712329707521
RT @PilarRiveraOrt1@twitter.com
@REMAP_ILD@twitter.com @IPFdoc@twitter.com @leticiakawano@twitter.com @RogerJLewis@twitter.com @BerryConsultant@twitter.com @KaminskiMed@twitter.com @KerriBerriKerri@twitter.com @ActionPFwendy@twitter.com @pfsg_nireland@twitter.com @ActionPFcharity@twitter.com It is a privilege to be part of this fabulous team worldwide π @REMAP_ILD@twitter.com We are a great family π€π« I wish all of you a Happy 2023! πππ #ILD #IPF #CureIPF #teamwork
RT @KerriBerriKerri@twitter.com
Machine Learning in Radiology: The New Frontier in ILD
From @hayleynbarnes@twitter.com et al. in @LancetDigitalH@twitter.com
Comprehensive, accessible overview of machine learning, AI, radiomics (+more!) applications to #ILD π«
#OpenAccess #CurePF #CureIPF π―
https://www.thelancet.com/journals/landig/article/PIIS2589-7500(22)00230-8/fulltext
#ILD #openaccess #CurePF #CureIPF
RT @IPFdoc@twitter.com
@NeumologiaPeru@twitter.com @DrPujaMehta1@twitter.com @PilarRiveraOrt1@twitter.com @KerriBerriKerri@twitter.com @KaminskiMed@twitter.com @DrFaican@twitter.com @Katerin16265046@twitter.com @mariamolinao@twitter.com @scott_matson@twitter.com We should probably be screening for RA in patients with #ILD! @PhilippeDieude@twitter.com
RT @patientMpower@twitter.com
Great to be back at #BTSWinter2022!
Plenty of new patientMpower data - starting with a presentation from Dr Sarah Barth, here with our CSO Dr Colin Edwards, with an analysis on what affects adherence to home spirometry in #ILD
π¦π: https://twitter.com/patientMpower/status/1595409101982294018
A while back I started writing blog posts on how to analyze #IntensiveLongitudinalData using #STAN.
The idea was sharing code for some of the most used models like (hierarchical) AR and VAR models as well as explaining the #STAN syntax a bit π.
I want to pick it up again, but for now, here is an example discussing the hierarchical AR(1) model. Curious what you all think π.
https://experienced-sampler.netlify.app/post/stan-hierarchical-ar/
#Bayes #rstats #ESM #ILD #EMA #ExperienceSampling #EcologicalMomentaryAssessment
#intensivelongitudinaldata #stan #bayes #rstats #esm #ILD #ema #experiencesampling #ecologicalmomentaryassessment
RT @DrPujaMehta1@twitter.com
Huge honour π to join an π€© faculty & be invited back to:
@CleClinicMD@twitter.com Basic & Clinical Immunology Conference
π£οΈ Immunotherapeutics & Post-COVID19 #ILD
β° Feb 25-26 2023 HYBRID F2F / π» (freeπ°!)
*Early π¦ Reg Jan 20*
Fix that #ACR22 withdrawal!
#Introduction Hoping to communicate high quality information about lung health and respiratory medicine.
#COPD
#Asthma
#Lung
#ILD
#IPF
#RespIsBest
#Bronchiectasis
#COVID
#introduction #COPD #asthma #Lung #ILD #IPF #respisbest #bronchiectasis #COVID
#IVIg for acute exacerbations of #ILD
https://www.atsjournals.org/doi/full/10.1513/AnnalsATS.201603-179PS
My sense is the #AEILD #ILDflare therapy is wildly site-specific, altho perhaps less so than it once was
Do you use IVIg for acute exacerbations of ILD, and if so, which and when?
#ICUreadings #IVIg #ILD #AEILD #ILDflare
RT @PilarRiveraOrt1@twitter.com
You can see below my #MedTwitter @chirpty_team@twitter.com Glad to see many of my colleagues and friends from the #ILD community π«π Thanks for everything!
#ILDMastodon π« #ILD Community,
Personal reflection on important considerations in #IPF patients:
When a patient is diagnosed with idiopathic pulmonary fibrosis (IPF), the risk assessment, disease stage/severity, and initiation of antifibrotic treatment should not only be based on the percent predicted FVC. There are other important functional parameters (such as DLCO) or factors to be taken into account. π§΅
Dear #ILD community,
I would really appreciate it if you could help us spread this global survey. Thanks in advance π«π§¬π
On behalf of the IPF/ILD Respiratory Effectiveness Working Group, I invite you to participate in this global survey to identify characteristics of ILD diagnostic practice (virtual MDTs) in the #PostCOVID era. Project info and survey link below π
#ILD #ildmastodon #followlist #PostCovid
Dear #ILD community π«π§¬
I have created the #FollowList #ILDMastodon
By the way, I saw a good tip yesterday: If youβre using an iPhone for Mastodon, you can download an app called Metatext. I am using it and so far so good π€π»
Have a good weekend! ππ
Well this is new. Need to find everyone interested in #ILD #IPF and #AirPollution
#ILD and #sarcoidosis folks, I am trying to find you guys so I can follow but having a hard time... please reply to this message so I can find you guys